← Back to Portal 🏠 Dashboard

πŸ“š Rheumatology β€” L2: Seronegative Spondyloarthropathies

🎯 Exam Preparation Summary

πŸ“š Lecture Overview

This lecture covers Seronegative Spondyloarthropathies (SpA), a heterogeneous group of rheumatic diseases characterized by common clinical and genetic features without the presence of rheumatoid factor. The primary conditions discussed include Ankylosing Spondylitis (AS), Reiter's syndrome (Reactive Arthritis), and Psoriatic Arthritis (PsA). Mastering these disorders is crucial for diagnosing inflammatory back pain and peripheral arthropathies early to prevent irreversible joint damage and spinal fusion.

🎯 Key Concepts & Definitions

πŸ“– Main Content

1. Ankylosing Spondylitis (AS)

Ankylosing Spondylitis is a chronic inflammatory disease primarily affecting the axial skeleton.
- Patient History & Presentation:
- Insidious onset of low back pain before age 40 lasting > 3 months.
- Symptoms are worse in the morning or with inactivity and improve with exercise.
- Skeletal & Extra-articular Manifestations:
- Spinal involvement leads to flattening of the lumbar curve, exaggeration of thoracic curvature, and limited chest expansion.
- Uveitis occurs in up to 25% of patients.
- Cardiovascular complications include aortitis, aortic valve incompetence, and conduction abnormalities.
- Apical fibrobullous disease in the upper lung fields can mimic tuberculosis.
- Laboratory & Imaging:
- HLA-B27 is present in 90-95% of patients.
- X-ray reveals bilateral symmetrical sacroiliitis and bamboo spine due to syndesmophyte formation.
- MRI detects early bone marrow edema and inflammation.
- Diagnostic & Treatment Approach:
- Diagnosed using the 1984 New York criteria (clinical back pain criteria + radiological sacroiliitis).
- First-line medical therapy: Full anti-inflammatory doses of NSAIDs.
- Anti-TNF agents (e.g., adalimumab, infliximab) or IL-17 inhibitors (secukinumab) are used for patients unresponsive to NSAIDs.

2. Reactive Arthritis (Reiter's Syndrome)

A seronegative reactive arthritis triggered by specific genitourinary or enteric infections in genetically susceptible individuals.
- Classic Triad: Arthritis, conjunctivitis, and urethritis.
- Etiology: Triggered by Chlamydia, Mycoplasma, Salmonella, Shigella, or Yersinia infections.
- Clinical Features:
- Asymmetric poly- or oligoarthritis affecting knees and ankles, appearing 2–6 weeks post-infection.
- Mucocutaneous lesions include painless buccal ulcers, keratoderma blennorrhagica on the soles/palms, and circinate balanitis.
- HLA-B27 is present in 70-80% of patients.
- Treatment: Primarily NSAIDs, intra-articular steroids, and short-term antibiotics if an active infection persists.

3. Psoriatic Arthritis (PsA)

An inflammatory arthropathy occurring in 5-20% of patients with psoriasis, affecting axial and peripheral joints, nails, skin, and entheses.
- Clinical Patterns (Moll and Wright):
- Oligo-articular disease (asymmetric large/small joints).
- Distal interphalangeal (DIP) joint involvement with nail pitting.
- Arthritis mutilans (severe deforming arthritis with massive phalangeal destruction).
- Symmetric polyarthropathy resembling rheumatoid factor-negative RA.
- Psoriatic spondylitis (axial disease).
- Classification & Imaging:
- Diagnosed using the CASPAR criteria (requires inflammatory articular disease + score β‰₯ 3 from skin psoriasis, nail lesions, dactylitis, negative RF, and juxta-articular bone formation).
- Radiography shows pencil-in-cup changes, periostitis, and asymmetric syndesmophytes.
- Treatment Strategy:
- Mild disease: NSAIDs or apremilast.
- Moderate to severe peripheral arthritis: Conventional DMARDs like Methotrexate (MTX).
- Severe disease or axial involvement: TNF inhibitors or IL-17 inhibitors (secukinumab).

πŸ“Š Visual Learning

flowchart TD A[SpA Suspected] --> B{Check Features} B -->|Axial Predominant| C[Ankylosing Spondylitis] B -->|Post Infection| D[Reiter Syndrome] B -->|Skin Psoriasis| E[Psoriatic Arthritis] C --> F[HLA B27 90-95 percent] D --> G[Arthritis Urethritis Conjunctivitis] E --> H[CASPAR Criteria]
mindmap root("Seronegative SpA") "Ankylosing Spondylitis" "Bamboo Spine" "Bilateral Sacroiliitis" "Uveitis" "Reiter Syndrome" "Infection Trigger" "Asymmetric Arthritis" "Keratoderma Blennorrhagica" "Psoriatic Arthritis" "DIP Joint Involvement" "Pencil in Cup" "CASPAR Criteria"
sequenceDiagram participant P as Patient participant D as Doctor participant L as Lab / Imaging P ->> D: Inflammatory Back Pain > 3 months D ->> L: Order HLA-B27 and X-ray or MRI L ->> D: Report Sacroiliitis & Positive HLA-B27 D ->> P: Diagnose AS and start NSAID trial

πŸ’‘ Important Points to Remember

⚠️ Common Exam Questions

πŸ“ Quick Review Checklist

I can explain the clinical features and diagnostic criteria of Ankylosing Spondylitis
I understand the classic triad and infectious triggers of Reiter's syndrome
I can define the CASPAR criteria and radiographic findings of Psoriatic Arthritis
I know the role of HLA-B27 across the different seronegative spondyloarthropathies
I know the stepwise pharmacological management from NSAIDs to biologic agents